Publications

• Masana L, Pedro-Botet J, Civeira F. IMPROVE-IT clinical implications. Should the "high-intensity cholesterol-lowering therapy" strategy replace the "high-intensity statin therapy"? Atherosclerosis 2015 May; 240(1): 161-2

  IF: 3.971, Quartile: 1

  View abstract

• Lamiquiz-Moneo I, Bea AM, Mateo-Gallego R, Baila-Rueda L, Cenarro A, Pocoví M, Civeira F, De Castro-Orós I. [Identification of variants in LMF1 gene associated with primary hypertriglyceridemia]. Clin Investig Arterioscler 2015 Mar; 27(5): 246-52

  IF: 0

  View abstract

• Martin-Rodriguez S, Reverter JC, Tàssies D, Espinosa G, Heras M, Pino M, Escolar G, Diaz-Ricart M. Reduced ADAMTS13 activity is associated with thrombotic risk in systemic lupus erythematosus. Lupus 2015 Oct; 24(11): 1143-9

  IF: 2.481, Quartile: 3

  View abstract

• Onetti Y, Dantas AP, Pérez B, Cugota R, Chamorro A, Planas AM, Vila E, Jiménez-Altayó F. Middle cerebral artery remodeling following transient brain ischemia is linked to early postischemic hyperemia: a target of uric acid treatment. Am. J. Physiol. Heart Circ. Physiol. 2015 Apr; 308(8): H862-74

  IF: 4.012, Quartile: 1

  View abstract

• Echem C, Bomfim GF, Ceravolo GS, Oliveira MA, Santos-Eichler RA, Bechara LR, Veras MM, Saldiva PH, Ferreira JC, Akamine EH, Fortes ZB, Dantas AP, Carvalho MH, de Carvalho MH. Anti-toll like receptor 4 (TLR4) therapy diminishes cardiac remodeling regardless of changes in blood pressure in spontaneously hypertensive rats (SHR). Int. J. Cardiol. 2015 May; 187: 243-5

  IF: 6.175, Quartile: 1, Decile: 1

  View abstract

• Turczyńska KM, Swärd K, Hien TT, Wohlfahrt J, Mattisson IY, Ekman M, Nilsson J, Sjögren J, Hultgårdh-Nilsson VM, Murugesan V, Cidad P, Hultgårdh-Nilsson A, Hellstrand P, Pérez-García MT, Albinsson S. Regulation of smooth muscle dystrophin and synaptopodin 2 expression by actin polymerization and vascular injury. Arterioscler. Thromb. Vasc. Biol. 2015 Jun; 35(6): 1489-97

  IF: 5.533, Quartile: 1

  View abstract

• Tamargo J, Caballero R, Delpón E. Cancer chemotherapy and cardiac arrhythmias: a review. Drug Saf 2015 Feb; 38(2): 129-52

  IF: 2.62, Quartile: 2

  View abstract

• Tamargo J, Le Heuzey JY, Mabo P. Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide. Eur. J. Clin. Pharmacol. 2015 May; 71(5): 549-67

  IF: 2.697, Quartile: 2

  View abstract

• Martin-Rodriguez S, Caballo C, Gutiérrez G, Vera M, Cruzado JM, Cases A, Escolar G, Diaz-Ricart M. TLR4 and NALP3 inflammasome in the development of endothelial dysfunction in uraemia. Eur. J. Clin. Invest. 2015 Feb; 45(2): 160-9

  IF: 2.834, Quartile: 1

  View abstract

• Villanueva MP, Mollar A, Palau P, Carratalá A, Núñez E, Santas E, Bodí V, Chorro FJ, Miñana G, Blasco ML, Sanchis J, Núñez J. Procalcitonin and long-term prognosis after an admission for acute heart failure. Eur. J. Intern. Med. 2015 Jan; 26(1): 42-8

  IF: 2.3, Quartile: 1

  View abstract

• Santas E, Sandino J, Chorro FJ, Méndez J, Miñana G, Núñez E, Sanchis J, Núñez J. Prognostic implications of pericardial effusion in acute heart failure: Does size matter? Int. J. Cardiol. 2015 Apr; 184: 259-61

  IF: 6.175, Quartile: 1, Decile: 1

  View abstract

• García-Blas S, Valero E, Escribano D, Bonanad C, Sanchis J, Núñez J. Guideliner use for the percutaneous treatment of right coronary artery arising from the left circumflex (L-type single coronary artery). Int. J. Cardiol. 2015 Apr; 185: 2-3

  IF: 6.175, Quartile: 1, Decile: 1

  View abstract

• Santas E, Chorro FJ, Miñana G, Méndez J, Muñoz J, Escribano D, García-Blas S, Valero E, Bodí V, Núñez E, Sanchis J, Núñez J. Tricuspid Regurgitation and Mortality Risk Across Left Ventricular Systolic Function in Acute Heart Failure. Circ. J. 2015; 79(7): 1526-33

  IF: 3.685, Quartile: 2

  View abstract

• Núñez J, Rabinovich GA, Sandino J, Mainar L, Palau P, Santas E, Villanueva MP, Núñez E, Bodí V, Chorro FJ, Miñana G, Sanchis J. Prognostic value of the interaction between galectin-3 and antigen carbohydrate 125 in acute heart failure. PLoS ONE 2015; 10(4): e0122360

  IF: 3.534, Quartile: 1, Decile: 1

  View abstract

• Rosano GM, Lewis B, Agewall S, Wassmann S, Vitale C, Schmidt H, Drexel H, Patak A, Torp-Pedersen C, Kjeldsen KP, Tamargo J. Gender differences in the effect of cardiovascular drugs: a position document of the Working Group on Pharmacology and Drug Therapy of the ESC. Eur. Heart J. 2015 Oct; 36(40): 2677-80

  IF: 14.723, Quartile: 1, Decile: 1

  View abstract